Let’s Continue the Conversation

>>>Let’s Continue the Conversation

As we roll up our sleeves to take on 2018, we are looking back at the successes of the year that just passed.  We are thankful for the opportunity to serve our clients and share our appreciation for connecting at the recent CHC2017 in Kansas City.

At Avelead, we pride ourselves in solving problems in a creative and comprehensive way.  Over the years, we have discovered that one of the most frustrating and potentially project-threatening issues that clients face is translation of the legacy Charge Description Master (CDM) into the Cerner Pricing Tool.  We address this need in the most efficient and effective manner with our proprietary solution we refer to as the Master Build Automation Tool (MBAT).  In addition, our knowledgeable and experienced consultants will help your team understand the impact of this data both clinically and financially. MBAT can be used not only for the CDM, but also for other Master Data files that are often a challenge to keep synchronized across your organizations (i.e. Item Master, Physician Master, Pharmacy Formulary, Room and Bed, etc.)

Avelead strives to ensure all projects stay on time, within budget, and eliminate disruption of the revenue stream by providing the necessary Leadership and Technology to deliver high quality Results.

While we complete our transition to 2018 and implement our plans for continued growth; we would like to invite you to visit us at HIMSS 2018 on March 5-9 in Las Vegas, NV.  We look forward to the opportunity to demonstrate this powerful tool to you in booth 11325.  It’s not too early to register, so let’s continue our conversation today.

We hope you have a Wonderful and Prosperous New Year!

John Goforth
Senior Director

Join Our Team


What Sets Avelead Apart?

Working with the Avelead provides you with a rapidly expanding base of opportunities, as we experience focused growth and expansion of our client base.

Click Here to Apply Today
By |2018-01-15T18:56:01+00:00January 15th, 2018|Avelead, MBAT|0 Comments